Express-News: Drug designed in San Antonio fights age-related diseases

Pictured (from left) are Rapamycin Holdings Chief Financial Officer Mark Horsey and Professors Randy Strong and Z. Dave Sharp.

A San Antonio company is trying to break into the pharmaceutical market with a new version of an old drug that it believes offers hope to two-legged and four-legged patients diagnosed with incurable or life-altering diseases.

Read the full story at Express-News

Share This Article!